Works matching DE "IDIOPATHIC pulmonary fibrosis"
Results: 4390
Aspergilloma coexisting with idiopathic pulmonary fibrosis: A rare occurrence.
- Published in:
- Journal of Postgraduate Medicine, 2013, v. 59, n. 2, p. 145, doi. 10.4103/0022-3859.113841
- By:
- Publication type:
- Article
Isolation, Structure Elucidation, and Biological Activity of the Selective TACR2 Antagonist Tumonolide and its Aldehyde from a Marine Cyanobacterium.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 50, p. 1, doi. 10.1002/chem.202401393
- By:
- Publication type:
- Article
Systemic Arterial Endothelial Function in Children and Young Adults with Idiopathic Pulmonary Arterial Hypertension: Is there a Relation to Pulmonary Endothelium-Dependent Relaxation?
- Published in:
- Pediatric Cardiology, 2014, v. 35, n. 5, p. 844, doi. 10.1007/s00246-014-0864-z
- By:
- Publication type:
- Article
Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
- Published in:
- Transplant International, 2019, v. 32, n. 4, p. 399, doi. 10.1111/tri.13382
- By:
- Publication type:
- Article
First report of a living liver graft in combined lung and liver transplantation.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 10, p. 1445, doi. 10.1007/s00228-024-03720-7
- By:
- Publication type:
- Article
IPF Update: FIBRONEER-IPF Study of Nerandomilast Meets Primary End Point.
- Published in:
- Patient Care (Online), 2024, p. 2
- By:
- Publication type:
- Article
Contribution to the floristic knowledge of eastern Irpinia and Vulture-Melfese area (Campania and Basilicata, southern Italy).
- Published in:
- Italian Botanist, 2019, n. 8, p. 1, doi. 10.3897/italianbotanist.8.37818
- By:
- Publication type:
- Article
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
- Published in:
- African Journal of Thoracic & Critcal Care Medicine, 2023, v. 29, n. 1, p. 30
- By:
- Publication type:
- Article
Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis.
- Published in:
- African Journal of Thoracic & Critcal Care Medicine, 2022, v. 28, n. 3, p. 135
- By:
- Publication type:
- Article
Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases.
- Published in:
- Cell Transplantation, 2023, v. 32, p. 1, doi. 10.1177/09636897231196489
- By:
- Publication type:
- Article
Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosis.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07529-7
- By:
- Publication type:
- Article
PLAC8 attenuates pulmonary fibrosis and inhibits apoptosis of alveolar epithelial cells via facilitating autophagy.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-024-07334-8
- By:
- Publication type:
- Article
International multidisciplinary team discussions on the diagnosis of idiopathic non-specific interstitial pneumonia and the development of connective tissue disease.
- Published in:
- European Clinical Respiratory Journal, 2021, v. 8, n. 1, p. 1, doi. 10.1080/20018525.2021.1933878
- By:
- Publication type:
- Article
Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment.
- Published in:
- European Clinical Respiratory Journal, 2021, v. 8, n. 1, p. 1, doi. 10.1080/20018525.2020.1853658
- By:
- Publication type:
- Article
LUNG-DIGIT SYNDROME ASSOCIATED WITH IDIOPATHIC PULMONARY FIBROSIS: CLINICAL, PATHOLOGICAL AND IMMUNOHISTOCHEMICAL FINDINGS IN THREE CATS.
- Published in:
- Lucrari Stiintifice: Seria Medicina Veterinara, 2018, v. 61, n. 3, p. 200
- By:
- Publication type:
- Article
Inhaled Kathon may induce eosinophilia‐mediated disease in the lung.
- Published in:
- Environmental Toxicology, 2020, v. 35, n. 1, p. 27, doi. 10.1002/tox.22839
- By:
- Publication type:
- Article
Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis.
- Published in:
- Turkish Journal of Medical Sciences, 2024, v. 54, n. 5, p. 900, doi. 10.55730/1300-0144.5866
- By:
- Publication type:
- Article
Transbronchial lung cryobiopsy for the diagnosis of diffuse parenchymal lung disease: Pitfalls and challenges, a single center experience.
- Published in:
- Turkish Journal of Medical Sciences, 2023, v. 53, n. 1, p. 100, doi. 10.55730/1300-0144.5563
- By:
- Publication type:
- Article
The respiratory manifestations in patients with primary Sjögren's syndrome: is interstitial lung disease related to disease activity?
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 5, p. 1704, doi. 10.55730/1300-0144.5513
- By:
- Publication type:
- Article
Evaluation of efficacy and safety of pirfenidone 200 mg tablets in patients with idiopathic pulmonary fibrosis in a real-life setting.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 6, p. 3082, doi. 10.3906/sag-2102-262
- By:
- Publication type:
- Article
Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study).
- Published in:
- Turkish Journal of Medical Sciences, 2018, v. 48, n. 4, p. 826, doi. 10.3906/sag-1802-196
- By:
- Publication type:
- Article
Co-occurrence of lung adenocarcinoma and pulmonary fibrosis in a patient: A comprehensive case study and review of existing literature on the successful utilization of nintedanib.
- Published in:
- Pharmacia (0428-0296), 2023, v. 70, n. 4, p. 1127, doi. 10.3897/pharmacia.70.e111820
- By:
- Publication type:
- Article
Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Pulmonary Therapy, 2024, v. 10, n. 4, p. 377, doi. 10.1007/s41030-024-00271-1
- By:
- Publication type:
- Article
Correction: Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 3, p. 295, doi. 10.1007/s41030-023-00226-y
- By:
- Publication type:
- Article
Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 2, p. 177, doi. 10.1007/s41030-023-00216-0
- By:
- Publication type:
- Article
Prognostic Significance of Obstructive Sleep Apnea in a Population of Subjects with Interstitial Lung Diseases.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 2, p. 223, doi. 10.1007/s41030-023-00215-1
- By:
- Publication type:
- Article
The Eyes Have It—for Idiopathic Pulmonary Fibrosis: a Preliminary Observation.
- Published in:
- Pulmonary Therapy, 2022, v. 8, n. 3, p. 327, doi. 10.1007/s41030-022-00198-5
- By:
- Publication type:
- Article
Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
- Published in:
- Pulmonary Therapy, 2022, v. 8, n. 2, p. 181, doi. 10.1007/s41030-022-00187-8
- By:
- Publication type:
- Article
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 2, p. 471, doi. 10.1007/s41030-021-00162-9
- By:
- Publication type:
- Article
PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in Italy.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 1, p. 267, doi. 10.1007/s41030-021-00155-8
- By:
- Publication type:
- Article
Interstitial Lung Diseases and Air Pollution: Narrative Review of Literature.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 1, p. 89, doi. 10.1007/s41030-021-00148-7
- By:
- Publication type:
- Article
The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 1, p. 35, doi. 10.1007/s41030-019-00108-2
- By:
- Publication type:
- Article
Patients' and Healthcare Professionals' Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 1, p. 93, doi. 10.1007/s41030-020-00111-y
- By:
- Publication type:
- Article
A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 2, p. 151, doi. 10.1007/s41030-019-0096-8
- By:
- Publication type:
- Article
Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 1, p. 55, doi. 10.1007/s41030-019-0087-9
- By:
- Publication type:
- Article
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 1, p. 103, doi. 10.1007/s41030-018-0056-8
- By:
- Publication type:
- Article
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002).
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 1, p. 59, doi. 10.1007/s41030-018-0053-y
- By:
- Publication type:
- Article
Current and Future Therapies for Idiopathic Pulmonary Fibrosis.
- Published in:
- Pulmonary Therapy, 2015, v. 1, n. 1, p. 1, doi. 10.1007/s41030-015-0009-4
- By:
- Publication type:
- Article
血清 LncRNA TUG1、miR-29a-3p 表达与特发性肺纤维化患者病变程度、肺功能及 PI3K/Akt/mTOR 信号通路的关系研究.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 24, p. 4766, doi. 10.13241/j.cnki.pmb.2024.24.041
- By:
- Publication type:
- Article
纤维化性间质性肺疾病抗纤维化治疗的单中心真实世界研究.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 20, p. 3956, doi. 10.13241/j.cnki.pmb.2024.20.043
- By:
- Publication type:
- Article
炙甘草汤通过抗氧化抑制博莱霉素诱导的小鼠肺纤维化.
- Published in:
- Progress in Modern Biomedicine, 2022, v. 22, n. 21, p. 4014, doi. 10.13241/j.cnki.pmb.2022.21.003
- By:
- Publication type:
- Article
麦门冬汤加减方对特发性肺纤维化小鼠 PI3K/AKT/mTOR 通路的调控.
- Published in:
- Progress in Modern Biomedicine, 2022, v. 22, n. 17, p. 3214, doi. 10.13241/j.cnki.pmb.2022.17.003
- By:
- Publication type:
- Article
特发性肺纤维化患者血清血管生成素 -2、潜在转化生长因子结合蛋白 2、 趋化因子配体 14 水平与预后的关系研究.
- Published in:
- Progress in Modern Biomedicine, 2022, v. 22, n. 7, p. 1301, doi. 10.13241/j.cnki.pmb.2022.07.022
- By:
- Publication type:
- Article
吡非尼酮联合乙酰半胱氨酸治疗IPF患者的疗效及机制分析.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 6, p. 1064, doi. 10.13241/j.cnki.pmb.2021.06.014
- By:
- Publication type:
- Article
Referral to pulmonary rehabilitation and palliative care services in people with idiopathic pulmonary fibrosis in England, 2010–2019.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2024, v. 34, n. 1, p. 1, doi. 10.1038/s41533-024-00387-6
- By:
- Publication type:
- Article
Bosentan and ambrisentan in the treatment of idiopathic pulmonary fibrosis: a meta-analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 3, p. 1183
- By:
- Publication type:
- Article
The efficacy and safety of pirfenidone in the treatment of HPS-related pulmonary fibrosis and Idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 22, p. 8411
- By:
- Publication type:
- Article
Oxidative stress and inflammation parameters-novel biomarkers for idiopathic pulmonary fibrosis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 3, p. 927
- By:
- Publication type:
- Article